Systemic chemotherapy options for metastatic bladder cancer (Q36500537)

14 August 2017

1 reference

title

Systemic chemotherapy options for metastatic bladder cancer (English)

1 reference

14 August 2017

1 reference

Arlene Siefker-Radtke

series ordinal

1

1 reference

14 August 2017

publication date

1 June 2006

1 reference

Expert Review of Anticancer Therapy

14 August 2017

published in

1 reference

14 August 2017

volume

6

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

877-885

1 reference

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Evaluating multiple treatment courses in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

A feasibility study of carboplatin with fixed dose of gemcitabine in "unfit" patients with advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.6.877

21 January 2018

Identifiers

DOI

10.1586/14737140.6.6.877

1 reference

14 August 2017

1 reference